Copyright: ©Author(s) 2026.
World J Transplant. Sep 18, 2026; 16(3): 120969
Published online Sep 18, 2026. doi: 10.5500/wjt.120969
Published online Sep 18, 2026. doi: 10.5500/wjt.120969
Table 4 Distribution of complement genetic abnormalities according to anti-factor H antibody status
| Complement genetic abnormality | AFH-positive (n = 15) | AFH-negative (n = 23) | Total n (%) |
| CFHR1/CFHR3 rearrangements | 9 | 21 | 30 (78.9) |
| Duplication | 6 | 13 | 19 |
| Heterozygous deletion | 2 | 6 | 8 |
| Homozygous deletion | 1 | 2 | 3 |
| CFH mutation | 3 | 4 | 7 (18.4) |
| Heterozygous mutation | 2 | 3 | 5 |
| Homozygous mutation | 1 | 1 | 2 |
| CFHR5 mutation | 1 | 1 | 2 (5.3) |
| CFB mutation | 1 | 1 | 2 (5.3) |
| No genetic abnormality identified | 4 | 0 | 4 (10.5) |
- Citation: Balwani M, Pasari A, Kashiv P, Ramteke V, Tolani P, Manuja N, Kurundwadkar M, Dubey S, Pawar T, Malde S, Gupta S, Sejpal K, Jeyachandran V, Kute VB. Kidney transplant outcomes in patients with complement dysregulation. World J Transplant 2026; 16(3): 120969
- URL: https://www.wjgnet.com/2220-3230/full/v16/i3/120969.htm
- DOI: https://dx.doi.org/10.5500/wjt.120969